The hemorrhage risk of dasatinib therapy

Blood. 2023 Jun 15;141(24):2917-2918. doi: 10.1182/blood.2023020399.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • 14-3-3 Proteins*
  • Dasatinib / adverse effects
  • Hemorrhage / chemically induced
  • Humans
  • Inflammation
  • Pyrimidines* / adverse effects

Substances

  • Dasatinib
  • 14-3-3 Proteins
  • Pyrimidines